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Abstract
Background: A task force of the International Association for the Study of Pain (IASP) has developed a classification of
chronic pain for the ICD-11 consisting of seven major categories. The objective was to test whether the proposed
categories were exhaustive and mutually exclusive. In addition, the perceived utility of the diagnoses and the raters’
subjective diagnostic certainty were to be assessed.
Methods: Five independent pain centers in three continents coded 507 consecutive patients. The raters received the
definitions for the main diagnostic categories of the proposed classification and were asked to allocate diagnostic
categories to each patient. In addition, they were asked to indicate how useful they judged the diagnosis to be
from 0 (not at all) to 3 (completely) and how confident they were in their category allocation.
Results: The two largest groups of patients were coded as either chronic primary pain or chronic secondary
musculoskeletal pain. Of the 507 patients coded, 3.0% had chronic pain not fitting any of the proposed categories
(97% exhaustiveness), 20.1% received more than one diagnosis. After adjusting for double coding due to technical
reasons, 2.0% of cases remained (98% uniqueness). The mean perceived utility was 1.9 ± 1.0, the mean diagnostic
confidence was 2.0 ± 1.0.
Conclusions: The categories proved exhaustive with few cases being classified as unspecified chronic pain, and they
showed themselves to be mutually exclusive. The categories were regarded as useful with particularly high ratings for
the newly introduced categories (chronic cancer-related pain among others). The confidence in allocating the
diagnoses was good although no training regarding the ICD-11 categories had been possible at this stage of the
development.
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Background
The International Association for the Study of Pain
(IASP) defines pain as an unpleasant sensory or emo-
tional experience associated with actual or potential
tissue damage or described in terms of such damage [1].
Chronic pain is pain that persists or recurs for longer
than three months [2, 3]. Chronic pain affects more than
20% of the population worldwide [4–7], accounts for up
to 20% of physician visits [8, 9], and emerged as an
important component in the global burden of disability
[10]. However, despite their importance, in the current
version of the International Classification of Diseases
(ICD-10), chronic pain conditions are not recognized in
a systematic way. Adequate representation in the ICD
has far-reaching consequences. The ICD is the global
standard of diagnostic classification and serves a wide
range of purposes: by international treaty, it supports
the world-wide collection of health statistics and the
collected data provide the basis most governments use
for their health policy, planning, and resource allocation
[11]. In addition, the codified criteria identify the
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conditions for research, so the ICD diagnoses inform
research agendas. Lastly, adequate diagnoses are
essential for treatment choices [12, 13].
Responding to this need, the IASP established a task
force consisting of pain experts from around the world
to develop a pragmatic classification of chronic pain for
the inclusion into the eleventh revision of the ICD. The
task force has presented a pragmatic, research-based
classification proposal, which comprises seven categories
of chronic pain conditions [2, 3]:
1. Chronic primary pain (e.g. irritable bowel
syndrome, ‘non-specific’ chronic low back pain,
fibromyalgia) [14]
2. Chronic cancer-related pain (e.g. chronic cancer
pain, chronic post-chemotherapy pain) [15]
3. Chronic postsurgical and posttraumatic pain
(e.g. chronic pain after amputation, chronic pain
after burns injury) [16]
4. Chronic neuropathic pain (e.g. chronic painful
polyneuropathy, chronic central post-stroke pain) [17]
5. Chronic secondary headache or orofacial pain (e.g.
chronic orofacial muscle pain) [18]
6. Chronic secondary visceral pain (e.g. chronic
visceral pain from persistent inflammation or from
vascular mechanisms) [19]
7. Chronic secondary musculoskeletal pain (e.g.
chronic musculoskeletal pain from persistent
inflammation, chronic musculoskeletal pain
associated with osteoarthritis) [20].
Importantly, several of these chronic pain conditions
hitherto have not been represented in the ICD, e.g.
chronic primary pain, chronic neuropathic pain and
chronic cancer-related pain. The seven large classes of
chronic pain comprise more detailed subdiagnoses,
capturing well-described pain problems (see examples in
parentheses). A patient presenting with chronic back pain,
for example, should be screened for red flags related to
chronic secondary musculoskeletal back pain [20]; if there
are no red flags, he or she would receive the diagnosis of
chronic primary musculoskeletal pain, which is a more de-
tailed subcategory of chronic primary pain [14]. This con-
trasts with the situation in ICD-10, in which there are a
great number of codes for chronic back pain, many
of them widely criticized [14, 20, 21]. In addition, the
only diagnoses represented are ones that are regarded
as chronic secondary musculoskeletal pain by the new
classification. All chronic pain diagnoses can be com-
bined with optional specifiers encoding pain severity
(which includes pain intensity, pain-related disability,
and pain-related emotional distress), the temporal
course of the pain, and the presence of psychosocial
factors [2, 3].
With the ICD-11, the WHO has introduced several new
features [22]. Among others, the World Health Organisa-
tion (WHO) implemented multiple parenting. Multiple
parenting means that diagnostic entities can have more
than one so-called parent, i.e. be listed under more than
one heading. This overcomes the problem that, previously,
one and the same disease could be classified, e.g. according
to etiology (as a neoplasm) and according to site (genito-
urinary system) with different codes. Now, the different
places will all link to one and the same code. In the area of
pain, an entity such as “Chronic chemotherapy-induced
pain” can now be subordinate to, e.g. “Chronic cancer pain”
(etiology) and “Chronic neuropathic pain” (mechanism). By
allowing the same entity to be included in two or more cat-
egories, multiple parenting represents an advance in the
systematic structure [2] that often also corresponds to dif-
ferent medical specialties (i.e. oncologist and neurologist).
Please note that the present authors use the term
‘diagnosis’ in a technical sense. The WHO recognizes
diseases, disorders, signs, symptoms, injuries, and rea-
sons for encounter as entities in the foundation of
ICD-11. We use the term diagnosis for the allocation of
a code for a cluster of frequently co-occurring
symptoms, for which further inclusion and exclusion
criteria apply. This may be a disease or a disorder. We
do not intend to imply any further claims regarding a
possible etiology or disease entity by calling something ‘a
diagnosis’.
Any new classification must demonstrate its quality
[11, 13]. Three relevant dimensions determining a classi-
fication’s quality are reliability, validity, and utility. Reli-
ability refers to the question of whether the same entity
is coded in the same way on different occasions, either
by different raters (inter-rater reliability) or by the same
rater (intra-rater reliability). Several factors impact
reliability measures: on the raters’ side, reliability may
be improved by training and conscientious practice;
on the classification’s side, clear, operationalized
criteria and limited complexity facilitate reliable clas-
sification [23, 24]. Validity has been discussed with
reference to particular diagnoses and whole classifica-
tion systems [25, 26]. Applied to a classification as a
whole, a valid classification would be one where the
boundaries of the diagnostic categories defined in the
conceptual realm correspond to separate entities in
external reality. It is apparent that this is an ideal,
attainable only in part and difficult to test empirically.
With respect to pain classification, the difficulty is
exacerbated since pain is a subjective experience and
external references are lacking [27]. Clinical use,
alongside public health use, is one of the main
purposes of the ICD [28], and the (WHO) has priori-
tized improvement of clinical utility during the ICD
revision [11, 26, 28]. Clinical utility is defined as the
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degree to which a classification system conceptualizes
diagnostic entities, contributes to the selection of ad-
equate treatment interventions, predicts clinical man-
agement needs, is applicable in clinical practice [29],
provides information about prognosis and treatment
outcome [26], and facilitates communication about
the phenomena described. Moreover, a clinically use-
ful classification system is easy to use [11]. Reliability
as well as clinical utility is improved if the categories
of a classification system have clear boundaries [13]
and the categories are mutually exclusive, exhaustive,
reliable, biologically plausible, and simple [30].
Two types of field tests can be distinguished to
evaluate clinical utility [11]. Formative field tests are
implemented during the process of developing a new
classification in order to obtain information on how to
improve the structure and content of the classification
system. Evaluative field tests are administered once a
first draft of the new classification system has been final-
ized, to evaluate different aspects of its application [29].
The field test described here represents a formative
field test. This implies that the classification was
tested at the implementation level it had at the time
of testing, which meant that only the seven top level
diagnoses could be tested. The fact that only the top
level diagnoses could be tested had important conse-
quences: One of the consequences for the testing pre-
sented here was that due to multiple parenting some
diagnoses are correctly subsumed under more than
one heading. In the final version (available at the
website of the ICD-11: https://icd.who.int/dev11), this
will be solved on the next level of the classification
and does not constitute a problem with a category
boundary.
The goal of the present pilot field test was the assess-
ment of:
1) the exhaustiveness of the basic categories of the
proposed classification for chronic pain: how many
cases of chronic pain cannot be classified by the
proposed classification and would be relegated to
the category “Chronic pain, unspecified”?
2) the clarity of the category boundaries: how many
cases of chronic pain would be allocated to more
than one category?
3) the perceived usefulness of the categories;
4) the confidence with which the coding clinicians
chose each category.
In order to gather pilot data with regard to these
questions, clinicians from several pain centers and one
primary care center participated and classified a number
of consecutive patients on the basis of the proposed
classification.
Methods
Participating institutions and raters
Several institutions on three continents participated in
the preliminary testing, which was carried out from 15
July – 31 August 2016 upon request by the WHO. The
participating raters worked at tertiary pain centers, ex-
cept for one Norwegian primary care center. (See Table 1
for an overview of the participating centers). The choice
of participating centers was mainly guided by their abil-
ity to carry out the testing in the timeframe of the
ICD-11 preparation process, both in terms of resources
and numbers of patients with chronic pain seen by them.
Centers were selected from IASP collaboration centers.
The raters were clinicians experienced with regard to
chronic pain, but without any formal training with re-
spect to the ICD-11, because such training was unavail-
able at that stage in the development. The definitions
themselves and the overview article [2] were the only
aid. Raters allocated ICD-11 codes to consecutive
patients as they were seen, and at conclusion of the data
collection time had coded a total number of 507
patients.
Material
All institutions received the definitions as they are pro-
vided in the ICD-11 and operationalized diagnostic cri-
teria for the following seven diagnoses:
1. Chronic primary pain
2. Chronic cancer-related pain
3. Chronic postsurgical and posttraumatic pain
4. Chronic neuropathic pain
5. Chronic secondary headache or orofacial pain
6. Chronic secondary visceral pain
7. Chronic secondary musculoskeletal pain
These diagnoses represent the top level of the classifi-
cation. Including the individual diagnostic categories
below the top level was not possible because they had
not been implemented in the ICD-11 foundation layer at
the time.
Procedure
The participating institutions were asked to code
100–150 consecutive patients according to the criteria
provided and report on the diagnoses, whether the
raters thought the patients’ conditions would fall
under more than one category (to assess category
boundaries) or whether they did not fit any of the
categories (to assess the exhaustiveness of the cat-
egories combined). In addition, the raters were asked
to rate the utility of each diagnosis and subjective
diagnostic certainty with which they allocated it.
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Diagnostic code
For each coded patient, it was recorded which diagnoses
he or she had received routinely on the basis of ICD-10
and the diagnoses he or she would receive according to
the ICD-11 diagnostic categories (1–7). For primary
care, patients also had received pain diagnoses from the
International Classification of Primary Care, Second
Edition (ICPC-2).
Category exhaustiveness
If the diagnosis did not fit any of the ICD-11 categories,
the raters were instructed to record this fact. For this
purpose, it was asked: “Did the patient have chronic pain
that did not fit any of the categories?” The answers were
used to investigate the proportion of diagnoses the seven
categories in combination could classify. A high number
of affirmative answers to this question would mean that
many instances of chronic pain cannot be classified with
the proposed system; conversely, low numbers of
affirmative answers point to good coverage of the field
of chronic pain by the proposed classifications.
Category boundaries
In order to determine the clarity of the category bound-
aries, the raters were asked whether the pain the patient
reported fitted into more than one category and, if so,
into which categories. Affirmative answers to this ques-
tion were taken to indicate a possible problem with cat-
egory boundaries with a few provisos. Positive answers
to this question may have different causes. Firstly, the
patient could have two comorbid pain complaints (i.e.,
chronic tension-type headache and knee osteoarthritis)
and would naturally receive two diagnoses. These cases
were easily discerned on the basis of the ICD-10 codes,
and were counted as co-existing pain conditions rather
than double categories. Secondly, the patient could have
a pain disorder that would be an instance of double par-
enting, such as cancer pain of a neuropathic nature. In
the actual classification, this would receive a single
diagnostic code that will be accessible via cancer-related
pain and via neuropathic pain. Because the present field
testing only extended to a level at which the double
parenting could not be expressed, double category as-
signments of this nature were regarded as artifacts of the
testing procedure. The remaining double codings were
deemed to be due to a lack of clarity of the category
boundaries. These cases were counted and high propor-
tions of these cases could indicate a possible problem
with category boundaries or their perception by the
raters.
Perceived clinical utility and subjective diagnostic certainty
In order to assess perceived clinical utility each clinician
rated on a four-point scale from 0 (not at all), 1 (some-
what), 2 (very) to 3 (completely) how useful they felt the
diagnosis was for each patient. The subjective feeling of
diagnostic certainty was rated on a four-point scale from
0 (not at all confident), 1 (somewhat), 2 (very) to 3
(completely confident). Mean scores for perceived utility
and diagnostic certainty were calculated for each
category, with higher scores indicating higher utility and
confidence, respectively.
Data analysis
The data were analyzed by descriptive methods. We
counted the diagnoses that the patients received using
the old ICD-10 classification and calculated the average
number per patient. For the new classification for
ICD-11, we also counted how many diagnostic codes
each patient had received. The maximum here would be
7 (all diagnoses applied to the person) and the minimum
0 (none of the 7 categories applied). To establish cat-
egory boundaries, theoretically, each patient should fall
into only one of the seven categories. Cases in which the
number of diagnoses allocated was higher than 1 were
therefore taken as indicative of a possible problem with
category boundaries, provided, they were not occasioned
by one of the possibilities outlined above in Section
"Category Boundaries". Cases in which the number was
0, were counted and assessed separately as cases in
which no diagnosis could be assigned by the raters: this
represents the case of chronic pain that cannot be classi-
fied within the system. In order to be certain that it had
not just been an oversight, we counted the answers to
Table 1 Participating institutions, cases coded by each center and the number of raters
Institution Country Type Patients rated Number of raters
Several Multidisciplinary Pain Centers (Aichi Med. Univ., Ehime Univ.,
Jikei Med. Univ., Kyushyu Univ., Univ. Tokyo, Osaka Univ., Saga Univ.,
Toyama Univ., Nihon Univ., Fukushima Med. Univ., Juntendo Univ.)
Japan Tertiary pain centers 91 14
Pain Medicine Center Royal Perth Hospital Australia Tertiary pain center 62 4
Deutsches Rotes Kreuz Schmerzzentrum (Mainz) Germany Tertiary pain center 150 2
Oslo University Hospital, Dept. of Pain Management and Research Norway Secondary and tertiary care 103 4
Edda Medical Center/Leangen Medical Center/Heimdal Helsehus
Medical Center (Trondheim)
Norway Primary care 101 3
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the explicit question of whether the patient had chronic
pain that was unclassifiable by the categories provided
and calculated the percentage of all cases that remained
unclassifiable within the tested classification. A high
percentage of unclassifiable cases would be indicative of
a problem with the exhaustiveness of the categories. For
each category, means and standard deviations for the
raters’ subjective diagnostic confidence and utility judge-
ments are reported.
Results
Diagnostic codes
The most frequently given codes were chronic primary
pain and chronic secondary musculoskeletal pain, prob-
ably partly reflecting their high incidence in primary,
secondary, and tertiary care. However, the low frequency
of chronic cancer-related pain, chronic headache or oro-
facial pain and chronic secondary visceral pain may also
reflect a recruitment bias in this small group of partici-
pating centers. The patients received on average 1.2 ±
0.7 ICD-11 codes (range 1–3). (See Fig. 1 for the distri-
bution across the seven ICD-11 categories). The patients
received, on average, 1.7 ± 1.2 ICD-10 codes (range: 1–
7). The most frequent ICD-10 codes were: F45.4 persist-
ent somatoform pain disorder (n = 60), M54.4 lumbago
with sciatica (n = 48), and M54.5 low back pain (n = 43);
the most frequent ICPC-2 codes were L18 muscle pain
(n = 13), A01 Pain general/multiple sites (n = 9), L02
Back symptom/complain (n = 8). In seven cases (1.2%),
the rater used a clearly erroneous ICD-11 code (as
compared with the ICD-10 codes and comments pro-
vided), e.g. coding a knee problem as visceral pain.
Exhaustiveness
Of the 507 coded patients, 15 were reported to have
chronic pain that failed to be represented by any of the
seven categories. These constitute 3.0% of the total and,
following ICD-11 procedure, would be classified as
“Chronic pain, unspecified”.
Category boundaries
Of the 507 patients coded, 102 patients (20.1%) were
classified as belonging to more than one category. Of
these, 36 (7.1%) were due to co-existence of two separate
pain conditions, and 23 (4.5%) to the fact that the level
of testing could not take into account multiple parent-
ing. In 33 (6.5%) cases, it appears that chronic primary
pain was given as an additional comorbid diagnosis in
order to express the presence of psychosocial factors in-
fluencing a diagnosis of secondary pain. These instances
will later be solved by use of an extension code for psy-
chosocial factors with all chronic pain diagnoses, and
hence will not constitute a problem with category
boundaries. After removal of all three types of artificial
cases, only 10 cases remained as potential double classi-
fications (2.0%) (see Fig. 1).
Perceived clinical utility and confidence
Generally, the diagnoses were rated as very useful (mean:
1.9 ± SD: 1.0; theoretical range: 0–3). The categories
judged as most useful were “Chronic cancer-related
Fig. 1 All cases (absolute numbers) and cases in which more than one diagnostic code was assigned, adjusted for various coding artefacts, such
as true comorbidity, multiple parenting, and missing extension codes. HA/OFP: Chronic headache or orofacial pain, MSP: Chronic secondary
musculoskeletal pain
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pain” (2.7 ± 0.5) and “Chronic neuropathic pain” (2.3 ±
0.8). The raters were confident in applying the diagnoses
(2.0 ± 1.0). The highest confidence was expressed with
regard to chronic cancer-related pain (2.8 ± 0.4) and
chronic neuropathic pain (2.2 ± 0.8). In general, the
divergence between the diagnostic categories was small
(see Table 2).
Discussion
The present study is the first to present field testing data
regarding the proposed classification of chronic pain for
the ICD-11. In a naturalistic setting, clinicians in four
countries applied the ICD-11 classification to con-
secutive patients testing the feasibility of its applica-
tion. They provided ratings of the clinical utility of
the suggested categories and their subjective diag-
nostic confidence. We explored whether the com-
bined categories exhausted the encountered pain
conditions and whether overlapping category assign-
ments pointed to a problem with category boundaries.
The clinicians involved in the testing were (except in
Australia) wholly independent of the task force that had
developed the classification. The general feedback re-
ceived from the participating institutions was very favor-
able, emphasizing the usability of, and need for, such a
classification. The individual diagnoses proposed were,
generally, judged useful. This was particularly true for
diagnoses not hitherto included in the ICD, namely
“Chronic cancer-related pain”, “Chronic neuropathic
pain”, and “Chronic postsurgical and posttraumatic
pain”. It is likely the utility will increase further, once
sub-level diagnoses are included, such as chronic
post-radiotherapy pain or chronic post-stroke pain. All
participating clinicians were experienced in ICD-10
(ICPC-2, respectively) coding and familiar with pain
syndromes, but specific training with regard to the
proposed ICD-11 codes was not available at that stage of
development of the classification. The fact that they still
expressed good confidence indicates that the proposed
system is readily usable. It is to be expected that – with
training and practice – the reliability and subjective
confidence will increase even further.
The proposal aimed at a good coverage of chronic pain
syndromes. In the present field test, about 3% of cases
were deemed not classifiable by the proposed classifica-
tion and would have to be classed as “Chronic pain, un-
specified”. It would be instructive to compare the data
obtained by use of the ICD-11 with those in previous
studies using the ICD-10. However, as chronic pain was
not represented systematically in previous versions, epi-
demiological studies on chronic pain were not able to
rely on ICD-10 codes [31–34], rendering it impossible to
determine the percentage of patients who previously fell
into the residual categories in the ICD-10. Our result in-
dicates that the proposed ICD-11 categories capture a
large majority of encountered chronic pain diagnoses.
This is an excellent result since relegating conditions to
a residual category is associated with a lack of informa-
tion about treatment choice for the individual patient
[35]. Scientifically, residual categories are associated with
a shortage of research [36].
Unclear category boundaries limit the reliability of
diagnostic categories. We therefore investigated the
number of cases in which more than one category was
assigned to a patient. Only in 20.1% of cases, two diag-
noses were allocated. This number decreased substan-
tially when true comorbidities were taken into account,
and it was adjusted for cases that were due to the artifi-
cial situation that only the top level was coded where
multiple parenting remained invisible. It is expected that
the provision of second level diagnoses and their opera-
tionalized criteria in subsequent field trials will eliminate
this problem. Excluding these cases, only 11.6% were
left. A third type of case was observed in connection
with chronic primary pain: a secondary pain syndrome
with a clear underlying disease, e.g. chronic osteoarth-
ritis, was exacerbated by psychological factors, e.g.
anxiety. Sometimes, this seems to have led raters to con-
clude that the patient should also receive a diagnosis of
chronic primary pain. This is not correct and the prob-
lem will be addressed once the specifiers are included in
Table 2 Mean ratings of usefulness for the proposed categories and subjective confidence in allocating the cases to the respective
categories
Diagnostic entity Perceived utility (mean ± SD) Subjective confidence (mean ± SD)
Chronic primary pain 1.7 ± 1.0 1.8 ± 1.0
Chronic cancer-related pain 2.7 ± 0.5 2.8 ± 0.4
Chronic postsurgical and posttraumatic pain 2.0 ± 0.9 2.2 ± 0.9
Chronic neuropathic pain 2.2 ± 0.8 2.2 ± 0.8
Chronic secondary headache or orofacial pain 1.9 ± 0.7 2.0 ± 0.6
Chronic secondary visceral pain 1.8 ± 0.8 1.8 ± 0.9
Chronic secondary musculoskeletal pain 1.9 ± 0.9 2.0 ± 0.9
Theoretical range of the ratings: 0 (not at all) to 3 (completely)
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the field testing (which was not an option at this time).
Since the specifier “with psychosocial factors” can be
combined with all diagnoses in the classification, it will
be easy to represent such cases. If the numbers are ad-
justed for all these cases, only 2.0% of cases remain in
which two diagnoses were allocated for a single condi-
tion. This points to a very good demarcation between
the categories.
In addition, we had asked the raters to judge the per-
ceived utility of the diagnosis for each individual case
and all diagnoses were rated as very useful, with the
highest scores for chronic cancer-related pain, chronic
neuropathic pain and chronic postsurgical and posttrau-
matic pain. However, the utility to be expected from the
implementation of the new diagnoses could not be fully
represented in the ratings of the clinicians for individual
cases. The extremely positive ratings for categories like
cancer and neuropathic pain could be additionally moti-
vated by preferences of some raters (and health care
systems), especially in tertiary care, for pathology-rooted
categories. Considering the presently unsatisfactory
situation with regard to (what will in future be called)
“primary pain conditions”, the relative improvement in
utility for the classification of primary pain could be
much higher than captured here.
It should be noted that the reported numbers of the
encountered diagnoses do not indicate prevalence of the
conditions. Sampling consecutive cases after a start date
does not allow for any such conclusion; it only shows
what kinds of conditions were encountered in the par-
ticipating pain centers during that time. Still, the newly
introduced “Chronic primary pain” diagnosis was the
most frequently used single diagnosis. These first results
indicate that this new diagnosis is well accepted, and a
major improvement compared to existing concepts (e.g.,
somatoform pain disorder; functional pain syndromes).
We had also asked for ICD-10 codes and ICPC-2 codes
for the patients, and inspection of these codes showed
that many patients had three and more ICD-10 codes.
Although no definite conclusion can be drawn due to
the different levels of the coding (top level in the field
testing vs. individual codes), it was also apparent that
with the new classification, for a majority of these cases,
fewer, and more suitable, diagnoses would become
available.
Recommendations
Individual comments received on cases and formulations
were reviewed carefully by the task force and should be
used to improve details of the classifications further.
When implementing the classification, the relevant
subcategories should be added. Formal training in the
use of the classification should be available after its
introduction into routine practice. Future research
should address questions of inter-rater reliability and
validity in different settings.
Limitations and future directions
The field testing was part of a formative field test and
helped to gain first insight into the clinical utility of the
classification in routine practice prior to its implementa-
tion in the ICD-11. To be of relevance for the ICD-11
preparation process, the formative nature of the testing
also meant that it had to be completed within a short
time frame. Only this way would have allowed changes
to main categories if a problem had been revealed by the
testing. The main aim was to investigate mutual category
exclusiveness and joint exhaustiveness rather than the
smooth applicability in various settings. For this purpose,
centers were chosen from the list of IASP cooperation
centers, if enough patients with a variety of chronic pain
complaints were seen and resources allowed clinicians to
engage in double coding, i.e. accomplish the double cod-
ing in addition to discharging their clinical duties. These
conditions were typically met by tertiary centers, but we
are happy that one primary center participated. This
represents a trade-off between speed of data collection/
variety of patients over the investigation of a variety of
settings. The relevance of the new pain classification in
primary care centers is discussed elsewhere [21].
Further limitations were its pilot character, which
implied the use of the classification’s top-level structure
only, the lack of formal inclusion and exclusion criteria
for the patients or in-depth data regarding their condi-
tions. Moreover, no checks were implemented to assure
that indeed consecutive patients were recruited, and that
patients were not selectively excluded from this list. All
raters were physicians who worked with patients with
chronic pain and were experienced ICD-10 users, but
had not received formal training using ICD-11 classifica-
tions. Different numbers of raters coded different
patients of differing populations. This allowed the main
purpose of the study (testing category boundaries and
exhaustiveness) but made further analyses impossible.
These analyses will be the focus of future field testing of
the new classification that will implement various field
testing strategies as e.g. elaborated by Keeley and
colleagues [37]. Since it will no longer be a study of the
formative phase, it will be able to use a full version of
the classification as it has now been implemented in the
ICD-11 and address questions of reliability and clinical
utility.
This article was concerned mainly with clinicians allo-
cating diagnoses on the basis of patient examinations. A
further group of persons working with the ICD codes
are non-clinicians coding diseases and health complaints
from documentation for statistical or reimbursement
purposes. Testing how the new classification of chronic
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pain performs in this context was beyond the scope of
the present study, but will be part of a large WHO-led
study regarding technical aspects of the ICD-11 codes,
coding rules, the browser infrastructure and its search
options as well as coding tools.
Conclusion
This pilot field testing indicated that the proposed classifi-
cation of chronic pain into one group of chronic primary
pain syndromes and six groups of chronic secondary pain
syndromes performed promisingly in real life, both in spe-
cialized pain centers and in one primary care center. The
categories were exhaustive with very few cases being rele-
gated to residual categories. They were also mutually ex-
clusive and the raters were able to allocate single
categories to the majority of cases even without any formal
training. All proposed categories were regarded as clinic-
ally useful by the raters with a particular emphasis on the
newly introduced categories of chronic cancer-related
pain, chronic neuropathic pain, and chronic postsurgical
and posttraumatic pain. Finally, the acceptance of the clas-
sification, and the subjective confidence in allocating the
diagnoses was good and one of the participating sites con-
tinues to use the ICD-11 codes in their clinical practice.
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